NEW YORK — Becton Dickinson said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a PCR-based test that can detect SARS-CoV-2 and the influenza A and B viruses.
The test has also received CE marking, BD said.
The BD SARS-CoV-2/Flu assay runs on the firm's BD Max platform and provides a positive or negative result for each virus using a single specimen within three hours.